What have we learned from recent clinical trials in early breast cancer treatment?
Next steps for niraparib for ovarian cancer following on from the ENGOT-OV16/NOVA trial
How can durvalumab be used in NSCLC?
What's next for Merkel cell carcinoma trials
Phase III METEOR trial: cabozantinib vs everolimus for advanced clear cell renal cell carcinoma